Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2 - eBioMedicine

2022-10-08 16:13:19 By : Mr. Wen Dan

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Please enter a term before submitting your search.

WHO. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.

Lavielle M mlxR: Simulation of Longitudinal Data. 2017.

WHO. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020.

Lavielle M mlxR: Simulation of Longitudinal Data. 2017.

DOI: https://doi.org/10.1016/j.ebiom.2022.104148

Permitted Read, print & download Redistribute or republish the final article Text & data mine Translate the article Reuse portions or extracts from the article in other works Sell or re-use for commercial purposes Elsevier's open access license policy

COVID-19 Resource Centre Access the latest 2019 novel coronavirus disease (COVID-19) content from across The Lancet journals as it is published.

We use cookies to help provide and enhance our service and tailor content and ads. To update your cookie settings, please visit the Cookie Preference Center for this site. Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals. Privacy Policy   Terms and Conditions   Accessibility